{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:42:28Z","timestamp":1791848548784,"version":"4.3.4"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.2895","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T14:31:01Z","timestamp":1587047461000},"page":"e202895","source":"Crossref","is-referenced-by-count":387,"title":["Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors"],"prefix":"10.1001","volume":"3","author":[{"given":"Motoo","family":"Nomura","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Nagatomo","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Analytical Chemistry, Ritsumeikan University College of Pharmaceutical Sciences, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichiro","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Analytical Chemistry, Ritsumeikan University College of Pharmaceutical Sciences, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"issue":"8","key":"zoi200144r1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma.","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi200144r2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"zoi200144r3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"6371","key":"zoi200144r4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"6371","key":"zoi200144r5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"6371","key":"zoi200144r6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"9","key":"zoi200144r7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2116\/analsci.18SCP10","article-title":"Application of 2-picolylamine derivatized ultra-high performance liquid chromatography tandem mass spectrometry for the determination of short-chain fatty acids in feces samples.","volume":"34","author":"Nagatomo","year":"2018","journal-title":"Anal Sci"},{"issue":"21","key":"zoi200144r8","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnv176","article-title":"Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis.","volume":"362","author":"Rios-Covian","year":"2015","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"zoi200144r9","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7030078","article-title":"Characterization a novel butyric acid-producing bacterium Collinsella aerofaciens subsp. shenzhenensis subsp. nov.","volume":"7","author":"Qin","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"zoi200144r10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/emi.2017.19.issue-1","article-title":"Formation of propionate and butyrate by the human colonic microbiota.","volume":"19","author":"Louis","year":"2017","journal-title":"Environ Microbiol"},{"issue":"6145","key":"zoi200144r11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"7480","key":"zoi200144r12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"7480","key":"zoi200144r13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"issue":"1","key":"zoi200144r14","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.1038\/s41598-018-32860-x","article-title":"Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate.","volume":"8","author":"Luu","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"zoi200144r15","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1073\/pnas.1815029116","article-title":"High ambient temperature dampens adaptive immune responses to influenza A virus infection.","volume":"116","author":"Moriyama","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"zoi200144r16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-017-02651-5","article-title":"Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases.","volume":"9","author":"Fellows","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"zoi200144r17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201073","article-title":"Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid.","volume":"13","author":"Yuille","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"zoi200144r18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade.","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"47","key":"zoi200144r19","doi-asserted-by":"publisher","first-page":"83155","DOI":"10.18632\/oncotarget.v8i47","article-title":"HDAC inhibitors enhance the immunotherapy response of melanoma cells.","volume":"8","author":"Booth","year":"2017","journal-title":"Oncotarget"},{"issue":"49","key":"zoi200144r20","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1038\/onc.2015.46","article-title":"Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.","volume":"34","author":"Cao","year":"2015","journal-title":"Oncogene"},{"key":"zoi200144r21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13148-017-0358-y","article-title":"Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy.","volume":"9","author":"Mazzone","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"3","key":"zoi200144r22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2217\/epi.15.118","article-title":"Histone deacetylase inhibitors as immunomodulators in cancer therapeutics.","volume":"8","author":"Shen","year":"2016","journal-title":"Epigenomics"},{"issue":"7","key":"zoi200144r23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/BF02708379","article-title":"Applications of inulin and oligofructose in health and nutrition.","volume":"27","author":"Kaur","year":"2002","journal-title":"J Biosci"},{"issue":"10","key":"zoi200144r24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood.","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"issue":"6","key":"zoi200144r25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.clnu.2009.05.011","article-title":"Short chain fatty acids exchange across the gut and liver in humans measured at surgery.","volume":"28","author":"Bloemen","year":"2009","journal-title":"Clin Nutr"},{"issue":"10","key":"zoi200144r26","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102393","article-title":"Food components and dietary habits: keys for a healthy gut microbiota composition.","volume":"11","author":"Rinninella","year":"2019","journal-title":"Nutrients"},{"key":"zoi200144r27","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1038\/ncomms7342","article-title":"Fat, fibre and cancer risk in African Americans and rural Africans.","volume":"6","author":"O\u2019Keefe","year":"2015","journal-title":"Nat Commun"},{"issue":"6052","key":"zoi200144r28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes.","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"33","key":"zoi200144r29","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.","volume":"107","author":"De Filippo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"zoi200144r30","doi-asserted-by":"publisher","first-page":"e02566","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers.","volume":"10","author":"Baxter","year":"2019","journal-title":"mBio"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2764580\/nomura_2020_oi_200144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T11:01:36Z","timestamp":1592823696000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2764580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2895","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}